Oliver Mobasser
Oliver Mobasser is a Senior Associate in the Healthcare and Life Sciences group of the London office of Latham & Watkins. He advises clients in the healthcare and life sciences industry on a range of technology, intellectual property, and data-focused transactions and matters.
Mr Mobasser helps emerging and established multinational pharmaceutical, biotechnology, digital health, and medical technology companies as well as their investors navigate:
• Strategic licenses and collaborations
• Product acquisitions, divestments, and carve-outs
• Manufacturing, supply, distribution, and other commercial agreements
• Data protection, as well as data use, re-use, and exploitation
• Research and development and clinical trials
He has particular expertise and has contributed to a number of publications and conferences in complex data protection matters in the life sciences sector, including matters related to use of data in the context of clinical trials and other research, anonymisation, pseudonymisation, digital health and AI solutions.
Prior to joining Latham, Mr. Mobasser practised at a leading law firm in Dublin, Ireland, and completed a secondment as in-house counsel for Shire Pharmaceuticals. He brings a multifaceted, multijurisdictional perspective to his work for clients across Europe and North America. He regularly writes about topics at the intersection of healthcare, technology, and regulation.
Practice Area
Panel
- Contributing Author
Qualified Year
- 2016
Experience
- Matheson LLP (2013 - 2018)
Qualification
- BCL in Law & Philosophy (2012)
Education
- University College Dublin (2012)
1 Contributions by Oliver Mobasser
PRACTICE NOTES
Digital health data protection in the UK and EU: wearables, AI diagnostics and electronic health records - GDPR/UK GDPR (DUAA 2025) case studies and compliance guidance
What is digital health?
Digital health is a broad umbrella describing how information and communication technologies are used to enhance prevention, diagnosis, treatment, monitoring, and the management of health conditions and lifestyle habits that influence wellbeing. Its rise reflects the coming together of healthcare and technology, and a move away from provider‑focused, ‘one size fits all’ delivery towards personalised, patient‑centred care.
This Practice Note explores data protection considerations across three digital health use cases:
Wearables
Use of artificial intelligence (AI) in medical diagnostics
Digital health records
Unlike mobile health (mHealth), which is limited to care delivered via mobile devices, digital health is wider in scope. It encompasses modern care models such as digital therapeutics, telemedicine, digitised health systems and electronic health records, as well as AI, machine learning and data analytics. For more on mHealth, see Practice Notes: Digital health—regulation of mHealth apps and medical software and mHealth—data protection considerations.
Digital health solutions can be applied at every stage of a person’s healthcare journey. Examples include:
prevention: in applications that analyse lifestyle, habits or...
Life Sciences
If you expected to see yourself on this page, click here.
